Updates are available Correction dated 2024-12-16
Click to view Correction: https://doi.org/10.1007/s11606-024-09265-w
-
Authors
Fromer, Debra L.
Luck, Meghan E.
Cheng, Wendy Y.
Mahendran, Malena
da Costa, Wilson L.
Pinaire, Megan
Duh, Mei Sheng
Preib, Madison T.
Ellis, Jeffrey J. https://orcid.org/0000-0003-3868-2695
-
Funding
Funding for this research was provided by:
GSK
- License Information
-
More Information
Article History
Received: 21 February 2024
Accepted: 10 September 2024
First Online: 2 October 2024
Change Date: 16 December 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11606-024-09265-w
Declarations:
:
: The study complied with all applicable laws regarding subject privacy. Study results are presented as aggregate analyses that do not allow for subject identification; thus, informed consent and ethics committee and Institutional Review Board approvals were not required.
: DLF is a paid consultant to GSK, and Johnson & Johnson/Janssen Pharmaceuticals. MEL is an employee of, and shareholder in, GSK. WYC was an employee of Analysis Group, Inc., a consulting company that received funding from GSK to conduct this study, at the time of the study. MM, WLdC, MP and MSD are employees of Analysis Group, Inc., a consulting company that received funding from GSK to conduct this study. MTP is an employee of, and shareholder in, GSK. JJE is an employee of, and shareholder in, GSK. Trademarks are the property of their respective owners (Optum).
